A Phase IIIb Double-Blind, Randomised, Placebo-Controlled Study of Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone.

Trial Profile

A Phase IIIb Double-Blind, Randomised, Placebo-Controlled Study of Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2016

At a glance

  • Drugs Idebenone (Primary)
  • Indications Friedreich's ataxia
  • Focus Therapeutic Use
  • Acronyms PROTI
  • Sponsors Santhera Pharmaceuticals
  • Most Recent Events

    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 10 May 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 24 Mar 2011 Additional trial locations (Austria, Germany, Netherlands) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top